{"id":4911,"date":"2024-11-11T10:27:03","date_gmt":"2024-11-11T04:57:03","guid":{"rendered":"https:\/\/lakshmishree.com\/news\/?p=4911"},"modified":"2024-11-11T10:27:05","modified_gmt":"2024-11-11T04:57:05","slug":"biocon-shares-rise-5-after-usfda-clears-bengaluru-facility-with-favorable-rating","status":"publish","type":"post","link":"https:\/\/lakshmishree.com\/news\/biocon-shares-rise-5-after-usfda-clears-bengaluru-facility-with-favorable-rating\/","title":{"rendered":"Biocon Shares Rise 5% After USFDA Clears Bengaluru Facility with Favorable Rating"},"content":{"rendered":"\n<p>Shares of Biocon rose by 5 percent on November 11 after the US Food and Drug Administration (FDA) granted its Bengaluru biologics unit a &#8220;Voluntary Action Indicated&#8221; (VAI) status. This designation is generally positive, indicating minor issues found during the inspection but no need for regulatory or enforcement action, allowing Biocon to continue operations smoothly.<\/p>\n\n\n\n<p>At 09:27 am, Biocon\u2019s shares were trading at Rs 335 on the NSE, with a strong year-to-date increase of over 33 percent. The FDA inspection, conducted between July 15-26, covered six biologics manufacturing units, including drug substance and drug product facilities, as well as various laboratories and warehouses.<\/p>\n\n\n\n<p>The timely FDA clearance is in line with the fact that the Malaysia unit of Biocon was in the line of vision seeking regulatory approval, a key focus for investors.<\/p>\n\n\n\n<p>On the contrary, Biocon reported an 84 percent YoY sharp decline in net profit to Rs 27.1 crore in Q2FY25 from Rs 172 crore, while EBITDA margin also fell at 19% versus 21% of the firm. Revenue rose a rather modest at 4% at Rs 3590.4 crore.<\/p>\n\n\n\n<p>Do you have a news tip for Lakshmishree reporters? Please email us at <a>media@lakshmishree.com<\/a><\/p>\n\n\n\n<p><sub><sup><a href=\"Source: Moneycontrol\">Source: <\/a><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/biocon-shares-surge-5-after-usfda-clears-bengaluru-unit-as-vai-12862484.html\" data-type=\"link\" data-id=\"https:\/\/www.moneycontrol.com\/news\/business\/markets\/biocon-shares-surge-5-after-usfda-clears-bengaluru-unit-as-vai-12862484.html\" target=\"_blank\" rel=\"noopener\">Moneycontrol<\/a><\/sup><\/sub><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares of Biocon rose by 5 percent on November 11 after the US Food and Drug Administration (FDA) granted its Bengaluru biologics unit a &#8220;Voluntary Action Indicated&#8221; (VAI) status. This designation is generally positive, indicating minor issues found during the inspection but no need for regulatory or enforcement action, allowing Biocon to continue operations smoothly. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4913,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[50],"tags":[653],"class_list":["post-4911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-indian-market","tag-biocon-usfda"],"_links":{"self":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/4911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/comments?post=4911"}],"version-history":[{"count":1,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/4911\/revisions"}],"predecessor-version":[{"id":4914,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/posts\/4911\/revisions\/4914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media\/4913"}],"wp:attachment":[{"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/media?parent=4911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/categories?post=4911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lakshmishree.com\/news\/wp-json\/wp\/v2\/tags?post=4911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}